Biopharmaceutical and Biomedicine Market Contributing Large Share

Biopharmaceutical and Biomedicine Market
Biopharmaceutical and Biomedicine Market


The global Biopharmaceutical and Biomedicine Market is estimated to be valued at US$ 561,375.9 million in 2022 and is expected to exhibit a CAGR of 9.6% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Biopharmaceuticals and biomedicine products play an important role in treating various diseases and provide improved quality of life. These products are being used for treatment of cancer, metabolic disorders, cardiovascular diseases, infectious diseases and others. Biopharmaceuticals offer targeted therapy with minimum side effects.

Market key trends:
One of the key trend in the Biopharmaceutical and Biomedicine Market is the increasing R&D investments in cell and gene therapy. Biopharmaceutical companies are investing significantly in development of new cell and gene therapies to treat various genetic and chronic diseases. For instance, Novartis invested around US$ 500 million to establish its cell and gene therapy manufacturing facilities in Stein, Switzerland. Similarly, Gilead Sciences acquired Kite Pharma for US$ 11.9 billion to strengthen its cell therapy portfolio. These heavy investments are expected to drive the growth of cell and gene therapy segment during the forecast period.
Segment Analysis
The global biopharmaceutical and biomedicine market is segmented into monoclonal antibodies, therapeutic proteins and vaccines. The monoclonal antibodies segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. This is because monoclonal antibodies have emerged as promising and effective treatments for various chronic diseases like cancer and autoimmune disorders.

Key Takeaways
The global biopharmaceutical and biomedicine market is expected to witness high growth, exhibiting CAGR of 9.6% over the forecast period 2022-2030, due to increasing prevalence of chronic diseases worldwide.

The market size is expected to reach US$ 561,375.9 million in 2022.

On the regional front, North America is expected to dominate the global biopharmaceutical and biomedicine market over the forecast period. This is attributed to presence of key players, increasing healthcare expenditure and growing research activities in the region. Europe is also expected to contribute significantly to the market growth.

Key players operating in the biopharmaceutical and biomedicine market are Amgen Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi, Eli Lilly and Company, AbbVie Inc., Novo Nordisk A/S, Bristol-Myers Squibb Company, NanoString, QIAGEN, Affimed GmbH, GSK plc., Merck KgaA, and Teva Pharmaceutical Industries Ltd. These companies are focusing on new product launches and strategic collaborations to strengthen their market position.

Read More:

https://www.dailyprbulletin.com/the-biopharmaceutical-and-biomedicine-market-promising-future-driven-by-technological-advancements/

 

Comments

Post a Comment

Popular posts from this blog

Integration of Internet of Things (IoT) in the Drug Device Combination Product Market Industry

Image
Drug Device Combination Product Market The integration of the Internet of Things (IoT) in the Drug Device Combination Product Market Industry has the potential to revolutionize patient care, enhance treatment outcomes, and transform healthcare delivery. IoT refers to the network of interconnected devices that collect and exchange data through the internet. When applied to drug device combination products, IoT enables real-time monitoring, remote patient management, and data-driven insights that can greatly improve the effectiveness and efficiency of healthcare. One of the key benefits of IoT integration in the industry is remote patient monitoring. Connected drug device combination products equipped with sensors and connectivity capabilities can collect patient data, such as vital signs, medication adherence, and symptom tracking. This data is transmitted in real-time to healthcare providers, enabling them to monitor patients remotely and make timely interventions. Remote monitoring
Read more

Positron Emission Tomography (PET) Scanners Market: Emerging Applications in Drug Development and Clinical Trials

Image
Positron Emission Tomography (PET) Scanners Market Positron Emission Tomography (PET) scanners have emerged as powerful tools with diverse applications in the field of medical imaging. Beyond their well-established role in clinical diagnostics, PET scanners are increasingly being utilized in drug development and clinical trials. The unique capabilities of PET imaging enable researchers and pharmaceutical companies to gain valuable insights into drug behavior, target engagement, and treatment efficacy, thereby revolutionizing the drug development process. One of the primary applications of PET scanners in drug development is the assessment of drug pharmacokinetics. PET imaging allows researchers to track the distribution, metabolism, and elimination of radiolabeled drugs in real-time. By monitoring the drug's journey in the body, researchers can identify potential drug-drug interactions, evaluate the drug's bioavailability, and optimize dosing regimens. Additionally, PET sca
Read more

Rising Adoption of Non-Invasive Beauty Treatments Boosting the Microdermabrasion Devices Market

Image
Microdermabrasion Devices Market The microdermabrasion devices market is experiencing significant growth due to the rising adoption of non-invasive beauty treatments. Non-invasive procedures have gained immense popularity in recent years as they offer effective solutions for skin rejuvenation and improvement without the need for surgical interventions or extensive downtime. Microdermabrasion, a non-invasive cosmetic treatment, has emerged as a preferred choice among individuals seeking to enhance their skin's appearance and address various skin concerns. One of the key drivers of the market's growth is the increasing demand for non-invasive procedures. Individuals are now more inclined towards minimally invasive cosmetic treatments that offer natural-looking results with minimal risk and recovery time. Microdermabrasion fits this preference perfectly, as it involves exfoliating the outer layer of the skin to reveal a smoother, more youthful complexion, without the need for an
Read more